This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: AIG, EBAY, AZO, DOW, MS


Apollo (APOL) estimates increased at Morgan Stanley. APOL estimates were raised through 2014, Morgan Stanley said. Management boosted guidance, given an expected turnaround in starts for 2013. Overweight rating and $48 price target.

Bristol-Myers (BMY) numbers cut at BMO. BMY estimates were reduced through 2013, BMO Capital said. Eliquis delay pushes out the model. Outperform rating and new $38 price target.

ConocoPhillips (COP) numbers lowered at Oppenheimer. Shares of COP now seen reaching $65, Oppenheimer said. Estimates also lowered on downstream spin off. Outperform rating.

Cytec (CYT) numbers lowered at Jefferies. Shares of CYT now seen reaching $63, Jefferies said. Estimates also lowered on imminent coatings exit. Hold rating.

Dell (DELL) numbers lowered at Jefferies. Shares of DELL now seen reaching $13, Jefferies said. Estimates also lowered on pressure by Huawei. Hold rating.

Darden (DRI) estimates, target reduced at Credit Suisse. Shares of DRI now seen reaching $48, according to Credit Suisse. Estimates also cut, given weaker sales trends. Neutral rating.

First Horizon (FHN) numbers reduced at BofA/Merrill. Shares of FHN now seen reaching $7.50, according to Bank of America/Merrill Lynch. Estimates also cut, given the company's new guidance. Underperform rating.

Harley-Davidson (HOG) numbers trimmed at UBS. Shares of HOG now seen reaching $49, UBS said. Estimates also lowered on stronger dollar. Neutral rating.

Hershey (HSY) estimates, target raised at Credit Suisse. Shares of HSY now seen reaching $78, according to Credit Suisse. Estimates also increased, as the company has multiple potential growth levers. Outperform rating.

JP Morgan (JPM) added to Conviction List at Goldman. Long-term story still intact.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.
2 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs